These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17510000)

  • 21. [Evaluation of the therapeutic efficacy of pravastatin in monothereapy and in association with gemfibrozil in hypercholesterolemia associated with moderate hyperglyceridemia].
    Napoli C; Lepore S; Ambrosio G; Chiariello M
    Cardiologia; 1992 Nov; 37(11):761-8. PubMed ID: 1298545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia.
    Tolentino MC; Ferenczi A; Ronen L; Poretsky L
    Endocr Pract; 2002; 8(3):208-12. PubMed ID: 12113634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-modifying and pleiotropic effects of gemfibrozil, simvastatin and pravastatin in patients with dyslipidemia.
    Doncheva NI; Nikolov KV; Vassileva DP
    Folia Med (Plovdiv); 2006; 48(3-4):56-61. PubMed ID: 17668698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
    Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
    Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of simvastatin in the treatment of hyperlipidemia].
    Lu ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Aug; 21(4):216-8, 253. PubMed ID: 8194433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil.
    van Puijenbroek EP; Du Buf-Vereijken PW; Spooren PF; van Doormaal JJ
    J Intern Med; 1996 Dec; 240(6):403-4. PubMed ID: 9010388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LDL-C goal attainment in patients who remain on atorvastatin or switch to equivalent or non-equivalent doses of simvastatin: a retrospective matched cohort study in clinical practice.
    Rublee DA; Burke JP
    Postgrad Med; 2010 Mar; 122(2):16-24. PubMed ID: 20203452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ciprofibrate versus gemfibrozil in the treatment of primary hyperlipidaemia.
    Knipscheer HC; de Valois JC; van den Ende B; Wouter ten Cate J; Kastelein JJ
    Atherosclerosis; 1996 Jul; 124 Suppl():S75-81. PubMed ID: 8831919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers.
    Koskinen P; Kovanen PT; Tuomilehto J; Manninen V
    Arch Intern Med; 1992 Jan; 152(1):90-6. PubMed ID: 1728934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease.
    Farnier M; Retterstøl K; Steinmetz A; Császár A
    Diab Vasc Dis Res; 2012 Jul; 9(3):205-15. PubMed ID: 22228773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia.
    Fazio S; Guyton JR; Polis AB; Adewale AJ; Tomassini JE; Ryan NW; Tershakovec AM
    Am J Cardiol; 2010 Feb; 105(4):487-94. PubMed ID: 20152243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-lowering effects of ezetimibe and simvastatin in combination.
    Ijioma N; Robinson JG
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):131-45. PubMed ID: 21453210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postprandial lipemia--effect of lipid-lowering drugs.
    Karpe F
    Atheroscler Suppl; 2002 May; 3(1):41-6. PubMed ID: 12044585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
    Roth EM; McKenney JM; Kelly MT; Setze CM; Carlson DM; Gold A; Stolzenbach JC; Williams LA; Jones PH
    Am J Cardiovasc Drugs; 2010; 10(3):175-86. PubMed ID: 20524719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproducible tendinitis-like symptoms related to statin therapy.
    Movahed MR; Samsamsharaiat SA
    J Clin Rheumatol; 2006 Dec; 12(6):320-1. PubMed ID: 17149069
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.